Monobody Based Therapeutic Drugs Market Outlook Segmental Revenue till 2026

https://www.pharmiweb.com/press-release/2021-02-19/monobody-based-therapeutic-drugs-market-outlook-k...

Monobodies are categorized under synthetic binding proteins in which fibronectin type III domain (FN3) is utilized as a molecular scaffold. Monoboides are the best alternative to antibodies to offer target-binding proteins. 

Notice

Commenting only available for logged in users